Dixon Mitchell Investment Counsel Inc. Purchases 3,819 Shares of Danaher Corporation $DHR

Dixon Mitchell Investment Counsel Inc. lifted its position in Danaher Corporation (NYSE:DHR) by 2.1% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 186,417 shares of the conglomerate’s stock after acquiring an additional 3,819 shares during the period. Danaher accounts for about 1.4% of Dixon Mitchell Investment Counsel Inc.’s investment portfolio, making the stock its 26th largest holding. Dixon Mitchell Investment Counsel Inc.’s holdings in Danaher were worth $42,756,000 at the end of the most recent reporting period.

Several other institutional investors have also recently made changes to their positions in DHR. Norges Bank bought a new position in shares of Danaher in the 4th quarter worth approximately $2,177,106,000. Viking Global Investors LP raised its position in shares of Danaher by 543.9% in the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after acquiring an additional 2,455,994 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Danaher by 104.7% in the 4th quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares in the last quarter. Generation Investment Management LLP raised its position in shares of Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares in the last quarter. Finally, Capital International Investors raised its position in shares of Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after acquiring an additional 1,487,768 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the subject of several research reports. Robert W. Baird decreased their target price on Danaher from $251.00 to $249.00 and set an “outperform” rating for the company in a research report on Friday, April 17th. Piper Sandler initiated coverage on Danaher in a research note on Thursday. They issued a “neutral” rating and a $200.00 price target on the stock. The Goldman Sachs Group cut their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Argus cut their price target on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a research note on Friday, April 24th. Finally, Guggenheim cut their price target on Danaher from $275.00 to $235.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $233.61.

Danaher Stock Performance

DHR stock opened at $179.95 on Friday. The company has a market cap of $127.37 billion, a P/E ratio of 34.81, a price-to-earnings-growth ratio of 2.40 and a beta of 0.81. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock’s fifty day moving average price is $180.93 and its 200-day moving average price is $204.78.

Danaher (NYSE:DHR) last released its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. The firm had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same period last year, the business posted $1.88 EPS. On average, equities analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be paid a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Danaher closed its $9.9 billion acquisition of Masimo, expanding its diagnostics and patient-monitoring portfolio with AI-enabled sensor technologies that could support longer-term growth. Danaher Boosts Product Portfolio With the Acquisition of Masimo
• Positive Sentiment: Cepheid, a Danaher company, donated Xpert Hemorrhagic Fever panel tests to support Ebola outbreak response in Africa, highlighting the company’s diagnostic relevance and public-health role. Cepheid Delivers Xpert Hemorrhagic Fever Panel Tests to Africa
• Positive Sentiment: Analysts noted strong performance in Danaher’s biotechnology unit, with bioprocessing demand and equipment orders rising, which supports the company’s 2026 growth outlook. Strong Performance Continues at DHR’s Biotechnology Unit: What’s Next?

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.